Stocks and InvestingStocks and Investing
Wed, February 17, 2021
Tue, February 16, 2021
Mon, February 15, 2021
Fri, February 12, 2021
Thu, February 11, 2021

Anupam Rama Upgraded (ANAB) to Buy and Increased Target to $40 on, Feb 11th, 2021


Published on 2024-10-27 15:36:24 - WOPRAI, Anupam Rama
  Print publication without navigation


Anupam Rama of JP Morgan, Upgraded "AnaptysBio, Inc." (ANAB) to Buy and Increased Target from $19 to $40 on, Feb 11th, 2021.

Anupam has made no other calls on ANAB in the last 4 months.



There are 2 other peers that have a rating on ANAB. Out of the 2 peers that are also analyzing ANAB, 0 agree with Anupam's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Anupam


  • David Nierengarten of "Wedbush" Upgraded from Hold to Buy and Increased Target to $35 on, Tuesday, October 27th, 2020
  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $36 on, Wednesday, October 14th, 2020